These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 36168925

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites.
    Jing W, Dong S, Luo X, Liu J, Wei B, Du W, Yang L, Luo H, Wang Y, Wang S, Lu H.
    Pharmacol Res; 2021 Feb; 164():105358. PubMed ID: 33285228
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.
    Wang Y, Shou JW, Li XY, Zhao ZX, Fu J, He CY, Feng R, Ma C, Wen BY, Guo F, Yang XY, Han YX, Wang LL, Tong Q, You XF, Lin Y, Kong WJ, Si SY, Jiang JD.
    Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947
    [Abstract] [Full Text] [Related]

  • 6. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
    Chen H, Ye C, Wu C, Zhang J, Xu L, Wang X, Xu C, Zhang J, Guo Y, Yao Q.
    Int J Biol Sci; 2023 May; 19(7):2097-2113. PubMed ID: 37151876
    [Abstract] [Full Text] [Related]

  • 7. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
    Li C, Ai G, Wang Y, Lu Q, Luo C, Tan L, Lin G, Liu Y, Li Y, Zeng H, Chen J, Lin Z, Xian Y, Huang X, Xie J, Su Z.
    Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
    [Abstract] [Full Text] [Related]

  • 8. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
    Chen H, Ye C, Cai B, Zhang F, Wang X, Zhang J, Zhang Z, Guo Y, Yao Q.
    BMC Cancer; 2022 May 20; 22(1):566. PubMed ID: 35596224
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Berberine alleviates high-energy and low-protein diet-induced fatty liver hemorrhagic syndrome in laying hens: insights from microbiome and metabolomics.
    Cheng X, Hu Y, Kuang J, Guo X, Cao H, Wu H, Hu G, Zhuang Y.
    Poult Sci; 2024 Aug 20; 103(8):103968. PubMed ID: 38959643
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
    Dong Y, Fan H, Zhang Z, Jiang F, Li M, Zhou H, Guo W, Zhang Z, Kang Z, Gui Y, Shou Z, Li J, Zhu R, Fu Y, Sarapultsev A, Wang H, Luo S, Zhang G, Hu D.
    Int J Biol Sci; 2022 Aug 20; 18(4):1381-1397. PubMed ID: 35280677
    [Abstract] [Full Text] [Related]

  • 15. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
    Chen H, Zhang F, Zhang J, Zhang X, Guo Y, Yao Q.
    Front Immunol; 2020 Aug 20; 11():588079. PubMed ID: 33072135
    [Abstract] [Full Text] [Related]

  • 16. Responses of human gut microbiota abundance and amino acid metabolism in vitro to berberine.
    Fu Y, Wang Y, Wang X, Sun Y, Ren J, Fang B.
    Food Funct; 2022 Jun 06; 13(11):6329-6337. PubMed ID: 35611943
    [Abstract] [Full Text] [Related]

  • 17. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R, Yang N, Kong B, Cao B, Feng D, Yu X, Ge C, Huang J, Shen J, Wang P, Feng S, Fei F, Guo J, He J, Aa N, Chen Q, Pan Y, Schumacher JD, Yang CS, Guo GL, Aa J, Wang G.
    Mol Pharmacol; 2017 Feb 06; 91(2):110-122. PubMed ID: 27932556
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
    Shi Y, Hu J, Geng J, Hu T, Wang B, Yan W, Jiang Y, Li J, Liu S.
    Biomed Pharmacother; 2018 Nov 06; 107():1556-1563. PubMed ID: 30257374
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.